Home HaluGen

HaluGen

acquired
-
Developer of DNA Testing and Personalized Psychedelic Pre-screening Platform
Basic
Enterprise Profile

Basic Information

HaluGen is developing a DNA testing and personalized psychedelic pre-screening platform that provides insights into genetic, personal, and family aspects to better inform psychedelic experiences, with the aim of improving patient care and reducing side effects and risks. HaluGen's gene-based psychedelic pre-screening platform will help assess an individual's overall sensitivity and risk when using psychedelics.
HaluGen Life Sciences Inc.
Vancouver,BritishColumbia,Canada
less than 15 people
July 01, 2020
info@halugen.com

Enterprise Profile

Industrial Sector
Drug Trial Internet Health Service Platform
Application Scenarios
Digital Therapeutics